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Abstract
This study describes the prevalence of culture-positive adenovirus serotypes in culture-positive
respiratory specimens sent to the Central Public Health Laboratory, Toronto, Ontario, Canada for
the period September 2007–June 2008. Total nucleic acid was extracted from virus cultures using
an automated extraction method followed by polymerase chain reaction and Sanger sequencing of
the adenovirus hexon gene hypervariable region 7. 73% of specimens (n = 70) were from patients
≤ 4 years of age. Of the 96 adenovirus isolates, the most common identified serotypes were
serotype 3 (n = 44, 46%), serotype 2 (n = 25, 26%), serotype 1 (n = 17, 18%), and serotype 21 (n
= 5, 5%). Adenovirus serotype 14 was not found in this study group. The leading serotype, Ad3,
was identified throughout the duration of the study period. Molecular methods allow for the
determination of circulating adenovirus serotypes and be used to document the spread of highly
virulent adenoviral serotypes into a region.
Findings
Adenovirus causes a range of diseases including respira-
tory tract infections, conjunctivitis, and gastroenteritis.
Recent respiratory outbreaks of a virulent strain of human
adenovirus 14 (Ad14) led to the deaths of nine people in
the United States during the 2006–2007 respiratory sea-
son [1]. As part of a respiratory viral pathogens initiative,
the Central Public Health Laboratory initiated a surveil-
lance program for the detection and typing of culture-pos-
itive adenovirus serotypes isolated from respiratory
specimens.
This program utilized molecular protocols previously
designed for the serotyping of adenoviruses [2]. The pur-
pose of this study was to determine the prevalence of cul-
ture-positive adenovirus serotypes in the Greater Toronto
Area during the 2007–2008 respiratory season and to
determine whether adenovirus 14 was circulating in this
region.
The Central Public Health Laboratory is the primary virol-
ogy diagnostics and reference facility for the Greater
Toronto Area, covering a population of 5.5 million (2006
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census data). The study included all adenovirus isolates
detected in culture that were linked to a respiratory speci-
men collected between September 1, 2007 and June 19,
2008.
Forty-two adenovirus control strains were purchased from
the American Type Culture Collection and the National
Institute of Health. Briefly, specimens were cultured on
rhesus monkey kidney cells (Diagnostic Hybrids, Athens,
OH, USA) in atmospheric air for 10 days followed by
post-culture direct fluorescence antibody staining for ade-
novirus (Diagnostic Hybrids, Athens, OH, USA).
Total nucleic acid was extracted from positive cultures fol-
lowing the off-board lysis protocol with the NucliSENS
easyMAG (bioMérieux). The extractions yielded 55 μL of
total nucleic acid per sample, which were subsequently
aliquoted by 5 μL amounts into PCR strip tubes to avoid
contamination of the extracted stocks of DNA.
Conserved segments surrounding the HVR-7 of the hexon
gene were targeted by primers described by Sarantis et al
[2]. 5 μL of amplicon was loaded with 1 μL of 6× Loading
Dye (Fermentas, Burlington, ON, Canada), and the Low
Range MassRuler DNA Ladder (Fermentas, Burlington,
ON, Canada) was used to estimate the concentration of
DNA in each sample. Both strands of the amplified DNA
were labeled using the BigDye Terminator v.3.1 Sequenc-
ing Kit (Applied Biosystems, Foster City, CA, USA). Each
sequencing reaction contained 2 μL BigDye Sequencing
RR-100, 3 μL Sequencing Buffer, 2 pmol of forward or
reverse primer, 10 ng of DNA, and PCR-grade water to a
total reaction volume of 20 μL. The labeling was carried
out by a BioRad iCycler with an initial denaturation step
of 96°C for 1 min, 25 cycles of denaturation at 96°C for
10 s, annealing at 55°C for 5 s, and elongation at 60°C for
4 min. Unincorporated BigDye was removed using the
DyeEx 2.0 Spin Kit (Qiagen, Mississauga, ON, Canada).
All samples were sequenced using the ABI Prism 3100
Genetic Analyzer (Applied Biosystems). Sequence editing
and alignment were completed with FinchTV and Clus-
talX 2.0 for Windows. BLAST results were ranked by score
and identity.
The Chi-squared test was used to estimate distributions of
adenovirus in patient subpopulations GraphPad Prism 5
(GraphPad Software, Inc. La Jolla, CA, USA) and values of
p < 0.05 were considered to be significant.
As none of the respiratory specimens were from known
respiratory outbreaks, all were considered sporadic cases
of respiratory illness. Patient characteristics are identified
in Table 1. 73% (70/96) of adenovirus isolates were from
patients who were ≤ 4 years of age. As shown in Table 1,
the most common adenovirus serotypes were Ad3 (46%,
n = 44/96), Ad2 (26%, 25/96), Ad1 (18%, 17/96) and
Ad21 (5%, 5/96). No Ad14 were identified among the
remaining isolates. The distribution of the four most com-
mon serotypes Ad3, Ad21, Ad2, and Ad1 between patients
≤ 4 years and >4 years of age was significantly different p
< 0.0001, χ2 = 24.43, df = 3). Patients ≤ 4 years of age had
the serotype distribution; Ad3 (37%, n=26/70), Ad2
(36%, n=25/70), Ad1 (21%, 15/70), and Ad21 (1%, 1/
70). Patients >4 years of age had the serotype distribution;
Ad3 (71%, n=17/24), Ad2 (0, n=0/24), Ad1 (4%, 1/24),
and Ad21 (17%, 4/24). An analysis of the temporal distri-
bution of serotypes identified an equitable distribution of
the major adenovirus serotype (Ad3) over all months of
the collection period.
The majority of isolates (93/96, 97%) were from sub-
groups B (serotypes 3,7,11,14,16,21,34, an 35) and C
(serotypes 1,2,5, and 6) which have been identified as res-
piratory pathogens in other previous studies [3-5]. From
these subgroups, Ad3, Ad2 and Ad1 were identified as the
most common serotypes in this study population as a
whole and within the subsets of patients ≤ 4 years of age.
It should be noted that the majority (70/96, 73%) of spec-
imens were from patients ≤ 4 years of age. This data is con-
sistent with recent surveys of adenovirus serotypes in
pediatric populations which have identified Ad1, Ad2,
Table 1: Serotype and age distribution of clinical isolates
Age Distribution (n)
Subgroup Serotype No. (%) of Isolates 0–4 yrs. >4 yrs
B 3 44*(46%) 26 17
21 5 (5%) 1 4
C1 1 7 *  ( 1 8 % ) 1 5 1
22 5  ( 2 6 % ) 2 5 0
51  ( 1 % ) 10
61  ( 1 % ) 10
D8 1  ( 1 % ) 0 1
45 1 (1%) 0 1
E4 1  ( 1 % ) 1 0
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and Ad3 as the most common circulating serotypes in
pediatric patients with acute respiratory disease [6,7]. The
predominance of Ad3 in the adult population has also
been described by previous authors in other geographic
regions [8].
The authors note that Ad14 was not identified in this
study. This data is comparable to a recent pediatric survey
from Texas which also failed to identify Ad14 despite pre-
vious reports of Ad14 in that region[7]. Acute respiratory
disease associated with Ad14 has been identified in New
York, Washington, Oregon and Texas [1] and the geo-
graphic location of our province adjacent to New York
State was suggestive that Ad14 might be circulating in
Ontario. Although no Ad14 was identified in the Greater
Toronto area, the authors note that this study does not
preclude the possibility that Ad14 or other novel geno-
types were circulating in other regions of the province.
Future studies over longer-time periods that rely on PCR
for the detection of respiratory adenoviruses may be able
to provide a more comprehensive understanding of circu-
lating adenovirus serotypes [9].
In conclusion, this study indicates that Ad3, Ad2, and Ad1
were the most common adenovirus serotypes circulating
in the Greater Toronto Area between September 1, 2007
and June 19, 2008. Ad14 was not identified in this patient
population during the period of analysis. This compre-
hensive means of typing adenovirus allow public health
laboratories to inform their stakeholders on the possibil-
ity of new emergent strains which in turn should allow the
stakeholders to undertake appropriate infection control
and public health steps when these strains arrive in a
region. It is evident from this study that sequence-based
methodologies for the typing of adenovirus from viral cul-
ture materials are an effective means of determining ade-
novirus serotypes in specific communities and
populations.
Abbreviations
Ad: adenovirus; Ad1: adenovirus serotype 1; Ad2: Adeno-
virus serotype 2; Ad3: adenovirus serotype 3; Ad14: aden-
ovirus serotype 14; HVR-7: hypervaiable region 7.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
RY undertook experiments and wrote initial manuscript,
AE assisted in sequencing protocols, EL assisted in PCR
optimization, and sequencing protocols, JB assisted in
experiment planning and resource acquisition, TM pro-
vided clinical specimens, LB undertook adenovirus cul-
ture detection, SJD planned, coordinated, and supervised
project and helped write manuscript.
Authors' information
Rani Yeung is an undergraduate student at the University
of Toronto. Ms. Yeung undertook this work as a Summer
project supported by the Ontario Government Summer
Experience Program.
References
1. Acute respiratory disease associated with adenovirus sero-
type 14–four states, 2006–2007.  MMWR Morb Mortal Wkly Rep
2007, 56(45):1181-1184.
2. Sarantis H, Johnson G, Brown M, Petric M, Tellier R: Comprehen-
sive detection and serotyping of human adenoviruses by PCR
and sequencing.  J Clin Microbiol 2004, 42(9):3963-3969.
3. Kajon AE, Moseley JM, Metzgar D, Huong HS, Wadleigh A, Ryan MA,
et al.: Molecular epidemiology of adenovirus type 4 infections
in US military recruits in the postvaccination era (1997–
2003).  J Infect Dis 2007, 196(1):67-75.
4. Wadell G. Molecular epidemiology of human adenoviruses.
Curr Top Microbiol Immunol 1984, 110:191-220.
5. Schmitz H, Wigand R, Heinrich W: Worldwide epidemiology of
human adenovirus infections.  Am J Epidemiol 1983,
117(4):455-466.
6. Hong JY, Lee HJ, Piedra PA, Choi EH, Park KH, Koh YY, et al.: Lower
respiratory tract infections due to adenovirus in hospitalized
Korean children: epidemiology, clinical features, and prog-
nosis.  Clin Infect Dis 2001, 32(10):1423-1429.
7. Laham FR, Jewell AM, Schoonover SL, Demmler GJ, Piedra PA: The
search for adenovirus 14 in children in Houston, Texas.  Pedi-
atr Infect Dis J 2008, 27(7):653-654.
8. Ryan MA, Gray GC, Smith B, McKeehan JA, Hawksworth AW,
Malasig MD: Large epidemic of respiratory illness due to ade-
novirus types 7 and 3 in healthy young adults.  Clin Infect Dis
2002, 34(5):577-582.
9. Roh KH, Kim J, Nam MH, Yoon S, Lee CK, Lee K, et al.: Comparison
of the Seeplex Reverse Transcription PCR Assay with the R-
mix Viral Culture and Immunofluorescence Techniques for
Detection of Eight Respiratory Viruses.  Ann Clin Lab Sci 2008,
38(1):41-46.